Start Date
September 30, 2017
Primary Completion Date
December 31, 2017
Study Completion Date
December 31, 2017
Mebendazole
Participants will be randomized using a 1:1 ratio to one of the two arms. Study participants eligible for treatment will be randomly assigned to one of the two treatment arms using a computer-generated stratified block randomization code.
Noguchi Memorial Institute for Medical Research - University of Ghana, Legon
Collaborators (1)
Yale University
OTHER
Noguchi Memorial Institute for Medical Research
OTHER
Ghana Health Services
OTHER_GOV
HopeXchange Medical Center, Ghana
UNKNOWN
Kintampo Health Research Centre, Ghana
OTHER
PATH
OTHER